SECTION 2. HAZARDS IDENTIFICATION
2.1 Classification of the substance or mixture
Not a hazardous substance or mixture.
2.2 GHS Label elements, including precautionary statements
2.3 Hazards not otherwise classified (HNOC) or not covered by GHS - none
SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula: H310BO3
Molecular Weight: 61.03 g/mol
CAS-No.: 13813-79-1
EC-No.: 237-478-7
SECTION 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
Move out of dangerous area.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2) and/or in section 11
Indication of any immediate medical attention and special treatment needed
no data available
SECTION 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Borane/boron oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available
SECTION 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing Vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.
SECTION 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire protection.
For precautions see section 2.
Conditions for safe storage, including any incompatibilities
Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated
SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Contains no substances with occupational exposure limit values.
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
Appearance
Form: solid
Odor
no data available
Odor Threshold
no data available
pH
no data available
Melting point/freezing point
no data available
Initial boiling point and boiling range
no data available
Flash point
not applicable
EVaporation rate
no data available
Flammability (solid, gas)
no data available
Upper/lower flammability or explosive limits
no data available
Vapor pressure
no data available
Vapor density
no data available
Relative density
1.435 g/cm3 at 25 °C (77 °F)
Water solubility
no data available
Partition coefficient: n-octanol/water
no data available
Auto-ignition temperature
no data available
Decomposition temperature
no data available
Viscosity
no data available
Explosive properties
no data available
Oxidizing properties
no data available
Other safety information
no data available
SECTION 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
Avoid moisture.
Incompatible materials
Potassium, Acid anhydrides
Hazardous decomposition products
Other decomposition products-no data available
In the event of fire: see section 5
SECTION 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
LD50 Oral-rat-2,660 mg/kg
Inhalation: no data available
Inhalation: no data available
Dermal: no data available
no data available
LDLO Subcutaneous-Infant-1,100 mg/kg
Remarks: Behavioral:Tremor. Diarrhoea Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhoea.
LD50 Subcutaneous-rat-1,400 mg/kg
Remarks: Behavioral:Somnolence (general depressed activity). Behavioral:Ataxia. Nutritional and Gross Metabolic:Changes in:Body temperature decrease.
LD50 Intravenous-rat-1,330 mg/kg
Remarks: Behavioral:Tremor. Diarrhoea Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhoea.
LD50 Subcutaneous-mouse-1,740 mg/kg
LD50 Intravenous-mouse-1,240 mg/kg
Remarks: Behavioral:Convulsions or effect on seizure threshold. Respiratory disorder Diarrhoea
LD50 Subcutaneous-guinea pig-1,200 mg/kg
Remarks: Behavioral:Tremor. Diarrhoea Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhoea.
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
no data available
IARC:
No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
ACGIH:
No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by ACGIH.
NTP:
No component of this product present at levels greater than or equal to 0.1% is identified as a
known or anticipated carcinogen by NTP.
OSHA:
No component of this product present at levels greater than or equal to 0.1% is identified as a
carcinogen or potential carcinogen by OSHA.
Reproductive toxicity
May damage fertility. May damage the unborn child.
Presumed human reproductive toxicant
Specific target organ toxicity -single exposure
no data available
Specific target organ toxicity -repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
Toxicity reported for borates in humans: ingestion or absorption may cause nausea, vomiting, diarrhea, abdominal cramps, anderythematous lesions on the skin and mucous membranes. Other symptoms include: circulatory collapse, tachycardia, cyanosis, delirium, convulsions, and coma. Death has been reported to occur in infants from less than 5 grams and in adults from 5 to 20 grams.
Stomach-Irregularities-Based on Human Evidence
SECTION 12. ECOLOGICAL INFORMATION
oxicity
Toxicity to fish
LC0-Lepomis macrochirus (Bluegill)-96.0 h
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available
SECTION 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contact a licensed professional waste disposal service to dispose of this material.
Contaminated packaging
Dispose of as unused product.
SECTION 14. TRANSPORT INFORMATION
DOT (US)
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods
SECTION 15. REGULATORY INFORMATION
SARA 302 Components
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.
SARA 313 Components
SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313.
SARA 311/312 Hazards
Acute Health Hazard, Chronic Health Hazard
Massachusetts Right To Know Components
No components are subject to the Massachusetts Right to Know Act.
Pennsylvania Right To Know Components
[10B]Orthoboric acid
CAS-No.
13813-79-1
New Jersey Right To Know Components
[10B]Orthoboric acid
CAS-No.
13813-79-1
California Prop. 65 Components
This product does not contain any chemicals known to State of California to cause cancer, birth defects, or any other reproductive harm.